Optimal and maximal eulipidemic therapy in diabetes: “Tailored” drug combinations and estrogen replacement von Suma, S, Krishnaiengar, S.R, Hegde, J, Basavaraju, N.C, Rama, D.V, Srilakshmi, M.A, Joshi, S, Vinaya, A.S, Narayan, G.S, Dayashankar, U, Sudha, B.S, Mamatha, A.H, Raja, G, Kalpana, T, Sumithra, N, Ishrath, N, Srikanth, J, Mahesh, B.A, Srikanta, S.S, Sharda, A

Volltext

Loss of Protective Sensation (LOPS) in NIDDM: Pathogenetic association with atherosclerosis and nephropathy? von Krishnaiengar, S.R, Suma, S, Hegde, J, Basavaraju, N.C, Rama, D.V, Srilakshmi, M.A, Joshi, S, Vinaya, A.S, Narayan, G.S, Dayashankar, U, Sudha, B.S, Mamatha, A.H, Raja, G, Kalpana, T, Sumithra, N, Ishrath, N, Srikanth, J, Mahesh, B.A, Srikanta, S.S, Sharda, A

Volltext

“Highest” international prevalence of incipient diabetic nephropathy (IDN) in Asian Indians with NIDDM: Genetic predisposition versus social deficiencies in diabetes care? von Srikanta, S.S, Krishnaiengar, S.R, Suma, S, Hegde, J, Basavaraju, N.C, Rama, D.V, Srilakshmi, M.A, Joshi, S, Vinaya, A.S, Narayan, G.S, Dayashankar, U, Sudha, B.S, Mamatha, A.H, Raja, G, Kalpana, T, Sumithra, N, Ishrath, N, Srikanth, J, Punitha, L, Sreelatha, C.G, Mahesh, B.A, Sharda, A

Volltext